XTX Topco’s ClearPoint Neuro CLPT Stock Holding History

XTX Topco’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,955	Closed	-$300K	–	3896
2025 Q4	$300K	Buy	+21,955	New	+$407K	0.01%	2066
2025 Q3	–	Sell	-27,396	Closed	-$327K	–	2660
2025 Q2	$327K	Buy	+27,396	New	+$345K	0.01%	1369
2025 Q1	–	Sell	-14,339	Closed	-$221K	–	2496
2024 Q4	$221K	Sell	14,339 -5,561	-28%	-$72K	0.02%	1477
2024 Q3	$223K	Buy	19,900 +6,890	+53%	+$66K	0.02%	1374
2024 Q2	$70.1K	Buy	13,010 +1,353	+12%	+$7.83K	0.01%	1469
2024 Q1	$79.3K	Buy	+11,657	New	+$81.5K	0.01%	1400

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

XTX Topco's CLPT Position: Q1 2026 in Review

XTX Topco sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 21,955 shares — an estimated $300K sold.

XTX Topco first reported a position in CLPT in Q1 2024 and held it in 6 quarters. The position peaked at $327K in Q2 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

XTX Topco reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 21,955 ClearPoint Neuro shares in Q1 2026, an estimated $300K.
XTX Topco first reported a position in ClearPoint Neuro in Q1 2024 and held it in 6 quarters.
XTX Topco's ClearPoint Neuro position peaked at $327K in Q2 2025.
118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.